Related Experiment Video
Updated: May 18, 2026
05:16
Single Drosophila Ommatidium Dissection and Imaging
Published on: August 19, 2011
Dopamine oxidation and autophagy.
Patricia Muñoz1, Sandro Huenchuguala, Irmgard Paris
1Molecular & Clinical Pharmacology, ICBM, Faculty of Medicine, University of Chile, Independencia 1027, Santiago 8380453, Chile.
Parkinson'S Disease
|September 12, 2012
Summary
Aminochrome, a dopamine oxidation product, is implicated in Parkinson's disease neurodegeneration. It disrupts autophagy by promoting α-synuclein aggregation and impairing microtubule function in dopaminergic neurons.
Area of Science:
- Neuroscience
- Molecular Biology
- Cell Biology
Background:
- Parkinson's disease (PD) neurodegeneration involves mitochondrial dysfunction, α-synuclein aggregation, oxidative stress, neuroinflammation, and impaired protein degradation.
- Dopaminergic neurons containing neuromelanin are particularly vulnerable in PD.
- Aminochrome, a dopamine oxidation product, is a proposed key player in this neurodegeneration.
Purpose of the Study:
- To explore the link between dopamine oxidation to aminochrome and autophagy dysfunction in dopaminergic neurons.
- To elucidate the role of aminochrome in the pathogenesis of Parkinson's disease.
Main Methods:
- Literature review and discussion of existing research on aminochrome, α-synuclein, and autophagy.
- Analysis of aminochrome's effects on chaperone-mediated autophagy and microtubule function.
Main Results:
- Aminochrome formation is linked to impaired autophagy in dopaminergic neurons.
- Aminochrome induces α-synuclein protofibril formation, inhibiting chaperone-mediated autophagy.
- Aminochrome adducts with tubulin disrupt microtubule-dependent autophagosome-lysosome fusion.
Conclusions:
- Aminochrome plays a critical role in Parkinson's disease pathogenesis by inducing mitochondrial dysfunction, oxidative stress, α-synuclein aggregation, and impaired protein degradation.
- Targeting aminochrome formation or its downstream effects may offer therapeutic strategies for Parkinson's disease.
Related Concept Videos
01:27Autophagy
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
01:36Delivery Pathways to the Lysosome
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
01:18Autophagic Cell Death
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:22Cellular Injury V: Apoptosis and Autophagy
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...